Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000730469-08-000027
Filing Date
2008-01-28
Accepted
2008-01-28 18:28:10
Documents
1
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 5  
1 PRIMARY DOCUMENT edgardoc.xml 5 3495
  Complete submission text file 0000730469-08-000027.txt   5435
Mailing Address 440 ROUTE 22 BRIDGEWATER NJ 08807
Business Address 440 ROUTE 22 BRIDGEWATER NJ 08807 908-566-3800
ALPHARMA INC (Issuer) CIK: 0000730469 (see all company filings)

EIN.: 222095212 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 440 ROUTE 22 EAST BRIDGEWATER NJ 08807
Business Address 908-566-3800
Spellman Thomas J III (Reporting) CIK: 0001405262 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-08593 | Film No.: 08555572